JRSIS Health Care Corp (JRSS) financial statements (2021 and earlier)

Company profile

Business Address NO. 38 SOUTH STREET
HEILONGJIANG PROVINCE, 150025
State of Incorp. FL
Fiscal Year End December 31
SIC 806 - Hospitals (benchmarking)
More info Complete financial analysis Financial benchmarking

Balance sheet (Statement of financial position) ($ in millions)

9/30/2019
TTM
12/31/2018
12/31/2017
12/31/2016
12/31/2015
12/31/2014
ASSETS
Current Assets
Cash, cash equivalents, and short-term investments 01101
Cash and cash equivalents 01101
Receivables 87531
Inventory, net of allowances, customer advances and progress billings 11100
Inventory 11100
Prepaid expense 21101
Deferred costs 0000 
Deposits current assets     0
Other undisclosed current assets 0    
Total current assets: 1210743
Noncurrent Assets
Property, plant and equipment 3826232220
Deposits noncurrent assets 11111
Deferred costs 1000 
Other undisclosed noncurrent assets 111   
Total noncurrent assets: 4038242421
TOTAL ASSETS: 5249322824
LIABILITIES AND EQUITY
Liabilities
Current Liabilities
Accounts payable and accrued liabilities 42100
Accounts payable 42100
Employee-related liabilities 00000
Taxes payable 0    
Debt 33221
Due to related parties 00001
Deferred tax liabilities0    
Other liabilities 00000
Other undisclosed current liabilities 00000
Total current liabilities: 75323
Noncurrent Liabilities
Long-term debt and lease obligation 2223171816
Long-term debt, excluding current maturities 311  
Capital lease obligations1923161816
Liabilities, other than long-term debt 1    
Deferred tax liabilities, net1    
Total noncurrent liabilities: 2323171816
Total liabilities: 3028202019
Stockholders' equity
Stockholders' equity attributable to parent 1413742
Common stock 00000
Additional paid in capital 22111
Accumulated other comprehensive income (loss) (1)(0)(1)(0)0
Retained earnings 1311631
Stockholders' equity attributable to noncontrolling interest 87543
Total stockholders' equity: 22201275
TOTAL LIABILITIES AND EQUITY: 5249322824

Income statement (P&L) ($ in millions)

9/30/2019
TTM
12/31/2018
12/31/2017
12/31/2016
12/31/2015
12/31/2014
Revenues 282418126
Revenue, net2418126
Cost of revenue
(Cost of Goods and Services Sold)
  (0)(0)(0)(2)
Gross profit: 282418114
Operating expenses (23)(17)(13)(9)(7)
Other undisclosed operating income 00003
Operating income: 67531
Nonoperating income (expense)
(Other Nonoperating Income (Expense))
 (0)(0)000
Interest and debt expense (1)(1)(1)(1)(1)
Income (loss) from continuing operations before equity method investments, income taxes: 4541(0)
Other undisclosed income from continuing operations before income taxes 11111
Income from continuing operations before income taxes: 67531
Income tax expense (3)(0)(0)(0)(0)
Net income: 37531
Net loss attributable to noncontrolling interest (1)(2)(2)(1)(0)
Net income available to common stockholders, diluted: 25321

Comprehensive Income ($ in millions)

9/30/2019
TTM
12/31/2018
12/31/2017
12/31/2016
12/31/2015
12/31/2014
Net income: 37531
Other undisclosed comprehensive income (loss) (1)1(1)(0)(0)
Comprehensive income: 28421
Comprehensive loss, net of tax, attributable to noncontrolling interest (1)(2)(1)(1)(0)
Comprehensive income, net of tax, attributable to parent: 15321

Statements sources

The financial statements are based on the company's filings with the The U.S. Securities and Exchange Commission (SEC) through the Electronic Data Gathering, Analysis, and Retrieval system (EDGAR). The information is derived from the 10-K and 10-Q reports submitted to the SEC in XBRL (eXtensible Business Reporting Language) format and presented according to the US GAAP Taxonomy. Please review the original filings for a more detailed information.

Login to ReadyRatios

 

Have you forgotten your password?

Are you a new user?

Login As
You can log in if you are registered at one of these services: